{"id":25437,"date":"2012-07-30T23:14:19","date_gmt":"2012-07-31T03:14:19","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=25437"},"modified":"2012-07-31T11:50:49","modified_gmt":"2012-07-31T15:50:49","slug":"oxys","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/07\/30\/oxys\/","title":{"rendered":"<em>oxy<\/em>&middot;s&#8221;&#8230;"},"content":{"rendered":"<div align=\"justify\">After the settlements or fines for misbehavior by the drug companies, critics make the same two points. The fine was &quot;too low&quot; considering the profit margin [the &quot;cost of business&quot; argument] and &quot;this won&#8217;t stop until they punish the people who did it&quot;. Those arguments might be gaining at least some traction with the escalating size of the settlements [GSK, J&amp;J]. And now this:  <\/div>\n<blockquote>\n<div align=\"center\"><u><strong><a href=\"http:\/\/www.pharmalot.com\/2012\/07\/court-purdue-executives-can-be-excluded-from-federal-programs\/\" target=\"_blank\"><font color=\"#200020\">Purdue Execs Can Be Excluded From Programs<\/font><\/a><\/strong><\/u><br \/>    <strong><font color=\"#004400\">Pharmalot<\/font><\/strong><br \/>    By Ed Silverman<br \/>    July 27th, 2012<\/div>\n<p>   <\/p>\n<div align=\"justify\"><sup>A  federal appeals court ruled today that the US Department of Health  &amp; Human Services can legally exclude three former Purdue Pharma  execs from doing business with federal healthcare programs such as  Medicare and Medicaid, because the drugmaker illegally branded the  powerful painkiller OxyContin. However, the court disagreed that HHS  sufficiently explained its decision to exclude the executives for 12  years, and sent the matter back to the agency for reconsideration. The executives singled out in the Purdue case were Michael Friedman,  Paul Goldenheim and Howard Udell. The case has been closely watched  because the exclusions would make it impossible for an executive to  continue a career in the pharmaceutical industry, as just about every  drugmaker does business with the US government in some fashion&#8230;<\/p>\n<p>       For those who may not recall, the government claimed Purdue  Frederick, a subsidiary of Purdue Pharma, misled patients, regulators  and doctors about the addictive risks of OxyContin. In 2007, the  subsidiary pled guilty to felony misbranding as part of a settlement and  was automatically debarred from winning new government contracts. The  parent company, which avoided criminal charges by striking a so-called  nonprosecution agreement and paying $600 million in fines, was allowed  to pursue contracts. Meanwhile, the three former execs were ordered to disgorge a total of  $34 million, although the drugmaker actually paid this amount, while  the trio avoided jail time. The former execs later argued, however, they  were innocent third parties, because there was no personal wrongdoing  and that excluding them from doing business with federal health care  programs was inconsistent with the law. They also maintained the 12-year  exclusion, which was reduced from 20 years, was unreasonable&#8230;<\/sup><\/div>\n<\/blockquote>\n<div align=\"justify\">I didn&#8217;t have any reason to keep up with the varieties of narcotics in my practice, but I do recall the introduction of OxyContin because of a specific patient. Actually, he was a former psychotherapy patient who later developed throat cancer requiring an operation and radiation. He&#8217;d been put on OxyContin [which I&#8217;d never heard of at the time]. He called me, almost incoherent and agitated one evening. I ended up talking to his wife [an MD]. She said he was on the new OxyContin because it was &quot;less addicting&quot; and it had been raised to 150 mg\/day [a huge dose] to control his pain. He had tried to lower the dose abruptly. We decided he was in withdrawal and she gave him his former dose. In the interim, I looked up OxyContin and it was advertised as having a low addiction potential.<\/div>\n<p align=\"justify\">What is OxyContin? Here are the structures of <strong><font color=\"#200020\">Heroin<\/font><\/strong>, <strong><font color=\"#200020\">Morphine<\/font><\/strong>, and <strong><font color=\"#200020\">Codeine<\/font><\/strong> &#8211; the naturally occurring opiates from the Opium Poppy. Below them are the two semisynthetics I was familiar with, <strong><font color=\"#200020\">Hydrocodone<\/font><\/strong> [Vicodin] and <strong><font color=\"#200020\">Oxycodone<\/font><\/strong> [Percodan]:  <\/p>\n<p align=\"center\"><img loading=\"lazy\" decoding=\"async\" width=\"400\" height=\"231\" border=\"0\" src=\"http:\/\/1boringoldman.com\/images\/opiates.gif\" \/><\/p>\n<p align=\"justify\">Not much different. So where is <strong><font color=\"#200020\">OxyContin<\/font><\/strong>? It&#8217;s just Oxycodone in a time release pill. When I found that out, I couldn&#8217;t figure any reason that it would be any less addicting than Percodan, and indeed, that turned out to be the case with this patient. It took a very long time with a slow taper to get him off the drug. He and I decided that the &quot;less addicting&quot; part wasn&#8217;t right. I later mentioned this story to a surgeon friend who said something like, &quot;Are you kidding! That drug is one of the worst.&quot; He went on to describe having the same experience of patients needing escalating doses, then having trouble detoxing. Anecdotes all &#8211; sure enough. But in these days of shaky official information, sometimes it&#8217;s the only information you can trust. Now, years later, we all know that OxyContin is highly addictive [and is a premium street drug &#8211; known as &quot;oxy&middot;s&quot;].<\/p>\n<p align=\"justify\">I mention that experience to highlight that this was a flagrant case of false advertising. And the justice system didn&#8217;t just slap their wrists [&quot;<em>In 2007, the  subsidiary pled guilty to felony misbranding as part of a  settlement and  was automatically debarred from winning new government  contracts<\/em>&quot;]. But here&#8217;s the important part. &quot;<em>Meanwhile, the three former execs were ordered to disgorge a total of  $34 million,  although the drugmaker actually paid this amount, while  the trio  avoided jail time<\/em>&quot; again didn&#8217;t directly punish the people who perpetrated the fraudulent misbranding. But they were excluded from doing business with federal healthcare programs. And on appeal, the court ruled that &quot;<em>the US Department of Health &amp; Human Services can legally exclude  three former Purdue Pharma execs from doing business with federal  healthcare programs such as Medicare and Medicaid, because the drugmaker  illegally branded the powerful painkiller OxyContin.<\/em>&quot; That&#8217;s a good thing. We&#8217;d like for those guys to be thrown in jail, but at least&nbsp; the court upheld HHS&#8217;s right to exclude offenders from further Pharma careers. It&#8217;s a start.<\/p>\n<div align=\"justify\">This was a flagrant [and stupid] scheme to increase profits. It was stupid because it was so obviously wrong. But hopefully it will start the trend of punishing the perpetrators, rather than allowing the company to pass the punishments on to the stockholders, while the actual wrong-doers hold on to their sales bonuses. The &quot;cost of doing business&quot; is going up&#8230;  <\/div>\n","protected":false},"excerpt":{"rendered":"<p>After the settlements or fines for misbehavior by the drug companies, critics make the same two points. The fine was &quot;too low&quot; considering the profit margin [the &quot;cost of business&quot; argument] and &quot;this won&#8217;t stop until they punish the people who did it&quot;. Those arguments might be gaining at least some traction with the escalating [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-25437","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/25437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=25437"}],"version-history":[{"count":16,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/25437\/revisions"}],"predecessor-version":[{"id":25467,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/25437\/revisions\/25467"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=25437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=25437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=25437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}